I'm a distinguished Global Clinical Operations Executive with more than 25 years of leadership experience driving complex Phase I–III clinical development programs across biotechnology, pharmaceutical, and contract research organizations. Throughout her career, she has successfully led global clinical operations, advanced innovative therapeutic programs across oncology, CNS, rare disease, and immunology, and contributed to multiple successful NDA/BLA approvals, including the first approval in immuno-oncology

Known for strategic vision and operational excellence, Meghann has built and transformed high-performing global organizations, led enterprise-wide operational initiatives, and delivered measurable business growth through scalable operating models, cross-functional leadership, and innovative clinical development strategies. Her expertise spans global clinical operations, AI enabled clinical innovation, decentralized and hybrid clinical trials, organizational transformation, regulatory readiness, vendor governance, and executive leadership

Driven by a commitment to advancing healthcare innovation, partners with executive leadership teams to accelerate clinical development, strengthen organizational performance, and deliver sustainable value for patients, partners, and stakeholders worldwide.